Together, these findings establish the DANCR–ABL2 axis as a central regulator of cytoskeletal reorganization and metastatic progression in neuroblastoma, bridging lncRNA function to kinase-driven cytoskeletal plasticity. This evidence concerns the gene ABL2 and neuroblastoma.